- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting the Host for New Therapeutic Perspectives in Hepatitis D
Authors
Keywords
-
Journal
Journal of Clinical Medicine
Volume 9, Issue 1, Pages 222
Publisher
MDPI AG
Online
2020-01-15
DOI
10.3390/jcm9010222
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- New treatment options for delta virus: Is a cure in sight?
- (2019) Cihan Yurdaydin JOURNAL OF VIRAL HEPATITIS
- Combined small molecule and loss-of-function screen uncovers estrogen receptor alpha and CAD as host factors for HDV infection and antiviral targets
- (2019) Eloi R Verrier et al. GUT
- PS-052-End of study results from LIMT HDV study: 36% durable virologic response at 24 weeks post-treatment with pegylated interferon lambda monotherapy in patients with chronic hepatitis delta virus infection
- (2019) Ohad Etzion et al. JOURNAL OF HEPATOLOGY
- GS-13-Final results of a multicenter, open-label phase 2 clinical trial (MYR203) to assess safety and efficacy of myrcludex B in cwith PEG-interferon Alpha 2a in patients with chronic HBV/HDV co-infection
- (2019) Heiner Wedemeyer et al. JOURNAL OF HEPATOLOGY
- Enveloped viruses distinct from HBV induce dissemination of hepatitis D virus in vivo
- (2019) Jimena Perez-Vargas et al. Nature Communications
- Comparison of anti-hepatitis D virus (HDV) ETI-AB-DELTAK-2 assay and the novel LIAISON® XL MUREX anti-HDV assay in the diagnosis of HDV infection
- (2019) Caterina Rocco et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Analysis of host responses to hepatitis B and delta viral infections in a micro-scalable hepatic co-culture system
- (2019) Benjamin Y. Winer et al. HEPATOLOGY
- Excellent safety and effectiveness of high dose myrcludex-b monotherapy administered for 48 weeks in hdv related compensated cirrhosis: a case report of three patients
- (2019) Alessandro Loglio et al. JOURNAL OF HEPATOLOGY
- Estimating the Global Prevalence, Disease Progression, and Clinical Outcome of Hepatitis Delta Virus Infection
- (2019) Zhijiang Miao et al. JOURNAL OF INFECTIOUS DISEASES
- Resistance analysis of genotype 3 hepatitis C virus indicates subtypes inherently resistant to nonstructural protein 5A inhibitors
- (2018) David Smith et al. HEPATOLOGY
- Optimizing lonafarnib treatment for the management of chronic delta hepatitis: The LOWR HDV-1 study
- (2018) Cihan Yurdaydin et al. HEPATOLOGY
- Hepatitis B virus evasion from cyclic guanosine monophosphate-adenosine monophosphate synthase sensing in human hepatocytes
- (2018) Eloi R. Verrier et al. HEPATOLOGY
- Phase Ib study of pevonedistat, a NEDD8-activating enzyme inhibitor, in combination with docetaxel, carboplatin and paclitaxel, or gemcitabine, in patients with advanced solid tumors
- (2018) A Craig Lockhart et al. INVESTIGATIONAL NEW DRUGS
- Final results of a multicenter, open-label phase 2b clinical trial to assess safety and efficacy of Myrcludex B in combination with Tenofovir in patients with chronic HBV/HDV co-infection
- (2018) H. Wedemeyer et al. JOURNAL OF HEPATOLOGY
- Hepatitis D virus replication is sensed by MDA5 and induces IFN-β/λ responses in hepatocytes
- (2018) Zhenfeng Zhang et al. JOURNAL OF HEPATOLOGY
- Prevalence and burden of hepatitis D virus infection in the global population: a systematic review and meta-analysis
- (2018) Hai-Yan Chen et al. GUT
- REP 2139: antiviral mechanisms and applications in achieving functional control of HBV and HDV infection
- (2018) Andrew Vaillant ACS Infectious Diseases
- Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, is a potent inhibitor of hepatitis B virus
- (2018) Kazuma Sekiba et al. HEPATOLOGY
- Hepatitis B virus evades innate immunity of hepatocytes but activates cytokine production by macrophages
- (2017) Xiaoming Cheng et al. HEPATOLOGY
- A phase 2 study exploring once daily dosing of ritonavir boosted lonafarnib for the treatment of chronic delta hepatitis – end of study results from the LOWR HDV-3 study
- (2017) C. Koh et al. JOURNAL OF HEPATOLOGY
- A phase 2 dose-escalation study of lonafarnib plus ritonavir in patients with chronic hepatitis D: final results from the Lonafarnib with ritonavir in HDV-4 (LOWR HDV-4) study
- (2017) H. Wedemeyer et al. JOURNAL OF HEPATOLOGY
- A phase 2 dose-optimization study of lonafarnib with ritonavir for the treatment of chronic delta hepatitis—end of treatment results from the LOWR HDV-2 study
- (2017) C. Yurdaydin et al. JOURNAL OF HEPATOLOGY
- Nucleic acid polymers are active against Hepatitis Delta Virus infection in vitro.
- (2017) Frauke Beilstein et al. JOURNAL OF VIROLOGY
- Hepatitis delta: virological and clinical aspects
- (2017) Luan Felipo Botelho-Souza et al. Virology Journal
- Interferon Lambda: Modulating Immunity in Infectious Diseases
- (2017) Mohammedyaseen Syedbasha et al. Frontiers in Immunology
- Nucleic acid polymers: Broad spectrum antiviral activity, antiviral mechanisms and optimization for the treatment of hepatitis B and hepatitis D infection
- (2016) Andrew Vaillant ANTIVIRAL RESEARCH
- Hepatitis B virus receptors and molecular drug targets
- (2016) Eloi R. Verrier et al. Hepatology International
- Cellular Nuclear Export Factors TAP and Aly Are Required for HDAg-L-mediated Assembly of Hepatitis Delta Virus
- (2016) Hsiu-Chen Huang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Performance Characteristics of a New Consensus Commercial Kit for Hepatitis D Virus RNA Viral Load Quantification
- (2016) Frédéric Le Gal et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Treatment of chronic hepatitis D with the entry inhibitor myrcludex B: First results of a phase Ib/IIa study
- (2016) Pavel Bogomolov et al. JOURNAL OF HEPATOLOGY
- The hepatitis delta virus: Replication and pathogenesis
- (2016) Camille Sureau et al. JOURNAL OF HEPATOLOGY
- Hepatitis B virus X protein identifies the Smc5/6 complex as a host restriction factor
- (2016) Adrien Decorsière et al. NATURE
- Hepatitis delta virus: insights into a peculiar pathogen and novel treatment options
- (2016) Florian A. Lempp et al. Nature Reviews Gastroenterology & Hepatology
- Hepatitis B Virus X Protein Promotes Degradation of SMC5/6 to Enhance HBV Replication
- (2016) Christopher M. Murphy et al. Cell Reports
- Safety and Efficacy of Nucleic Acid Polymers in Monotherapy and Combined with Immunotherapy in Treatment-Naive Bangladeshi Patients with HBeAg+ Chronic Hepatitis B Infection
- (2016) Mamun Al-Mahtab et al. PLoS One
- A targeted functional RNA interference screen uncovers glypican 5 as an entry factor for hepatitis B and D viruses
- (2015) Eloi R. Verrier et al. HEPATOLOGY
- Hepatitis Delta co-infection in humanized mice leads to pronounced induction of innate immune responses in comparison to HBV mono-infection
- (2015) Katja Giersch et al. JOURNAL OF HEPATOLOGY
- Protein neddylation: beyond cullin–RING ligases
- (2015) Radoslav I. Enchev et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Late HDV RNA relapse after peginterferon alpha-based therapy of chronic hepatitis delta
- (2014) Benjamin Heidrich et al. HEPATOLOGY
- Envelope Proteins Derived from Naturally Integrated Hepatitis B Virus DNA Support Assembly and Release of Infectious Hepatitis Delta Virus Particles
- (2014) N. Freitas et al. JOURNAL OF VIROLOGY
- Hepatitis D Virus Coinfection and Superinfection
- (2014) F. Negro Cold Spring Harbor Perspectives in Medicine
- Hepatitis B and D Viruses Exploit Sodium Taurocholate Co-transporting Polypeptide for Species-Specific Entry into Hepatocytes
- (2013) Yi Ni et al. GASTROENTEROLOGY
- Proteoglycans Act as Cellular Hepatitis Delta Virus Attachment Receptors
- (2013) Oscar Lamas Longarela et al. PLoS One
- A conformational heparan sulfate binding site essential to infectivity overlaps with the conserved hepatitis B virus A-determinant
- (2012) Camille Sureau et al. HEPATOLOGY
- Clinical Features of Hepatitis D
- (2012) Patrizia Farci et al. SEMINARS IN LIVER DISEASE
- Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus
- (2012) Huan Yan et al. eLife
- Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluation
- (2011) Marc Lütgehetmann et al. HEPATOLOGY
- Peginterferon plus Adefovir versus Either Drug Alone for Hepatitis Delta
- (2011) Heiner Wedemeyer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Quantitative longitudinal evaluations of hepatitis delta virus RNA and hepatitis B virus DNA shows a dynamic, complex replicative profile in chronic hepatitis B and D
- (2010) Melanie Schaper et al. JOURNAL OF HEPATOLOGY
- A 28-Year Study of the Course of Hepatitis Δ Infection: A Risk Factor for Cirrhosis and Hepatocellular Carcinoma
- (2009) Raffaella Romeo et al. GASTROENTEROLOGY
- Amphipathic DNA Polymers Inhibit Hepatitis C Virus Infection by Blocking Viral Entry
- (2009) Takuya Matsumura et al. GASTROENTEROLOGY
- Hepatitis delta virus proteins repress hepatitis B virus enhancers and activate the alpha/beta interferon-inducible MxA gene
- (2009) V. Williams et al. JOURNAL OF GENERAL VIROLOGY
- Amphipathic DNA Polymers Exhibit Antiherpetic Activity In Vitro and In Vivo
- (2008) D. I. Bernstein et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein
- (2008) Joerg Petersen et al. NATURE BIOTECHNOLOGY
- Characterization of the nuclear localization signal of the hepatitis delta virus antigen
- (2007) Carolina Alves et al. VIROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now